Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BTRU-GEMS logo.jpg

Gates S, ET AL, 2023, OPEN FORUM INFECTIOUS DISEASES. Investigating Blood Donors With Postdonation Respiratory Tract Symptoms During the Wild-Type, Delta, and Omicron Waves of the Coronavirus Disease 2019 Pandemic in England.

Fu M, Et AL. 2023,  J MED VIROL. Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult hepatitis B virus infection in English blood donors.

Gates S, ET AL., 2023, J Med Virol. 'Postpandemic rebound of adeno-associated virus type 2 (AAV2) infections temporally associated with an outbreak of unexplained severe acute hepatitis in children in the United Kingdom.  


Harvala H and SiMmonds P., 2022, TRANSFUSION MED. 'Evaluating the risk of transfusion and transplant-transmitted monkeypox infections'

Ratcliff et al., 2022, JC Microbiology. ‘Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCR’

Mehew et al., 2022, Transfusion Med. ‘Convalescent plasma for COVID-19: Donor demographic factors associated high neutralising antibody titres’

Blackstone et al., 2022, BMJ Open. ‘Protocol for the COG-UK hospital-onset COVID-19 infection (HOCI) multicentre interventional clinical study: evaluating the efficacy of rapid genome sequencing of SARS-CoV-2 in limiting the spread of COVID-19 in UK NHS hospitals’

Pitt et al., 2022, Int J STD AIDS. ‘Whole-genome sequencing of Chlamydia trachomatis isolates from persistently infected patients’

Harvala et al., 2021, Transfusion. ‘Hepatitis B infections among blood donors in England between 2009 and 2018: Is an occult hepatitis B infection a risk for blood safety?’